Holtzman Douglas
Officer at Icosavax, Inc.
- Sold, on record
- $608k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jul 3, 2023
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Icosavax, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Icosavax, Inc.Plan not statedAug 2, 2022 2022
Sold 10,375 shares at $6.67 ($69k)
Holtzman Douglas, Chief Scientific Officer
Sold 3.4% of holdings ($2M position)293,258 shares leftFirst sale on recordFiling
- 2 Form 4 sale Icosavax, Inc.UnusualDec 15, 2022 +135 days
Sold 19,648 shares at $11.14 ($219k)
Holtzman Douglas, Chief Scientific Officer
Sold 87.6% of holdings ($250k position)2,792 shares leftFiling
- 3 Form 4 sale Icosavax, Inc.Plan not statedFeb 14, 2023 +61 days
Sold 4,871 shares at $10.33 ($50k)
Holtzman Douglas, Chief Scientific Officer
Sold 1.7% of holdings ($3M position)290,054 shares leftFiling
- 4 Form 4 sale Icosavax, Inc.RoutineApr 3, 2023 +48 days
Sold 20,443 shares at $6.09 ($124k)
Holtzman Douglas, Chief Scientific Officer
10b5-1 planSold 6.6% of holdings ($1.9M position)290,054 shares left2x usual sizeFiling
- 5 Form 144 notice Icosavax, Inc.NoticeJul 3, 2023 +91 days
Filed to sell 16,356 shares ($162k)
Holtzman Douglas, Officer
10b5-1 plan1.1x usual sizeFiling
- 6 Form 4 sale Icosavax, Inc.RoutineJul 3, 2023 same day
Sold 16,356 shares at $8.85 ($145k)
Holtzman Douglas, Chief Scientific Officer
10b5-1 planSold 5.3% of holdings ($2.7M position)290,054 shares left1.1x usual sizeFollows a Form 144Filing
- 7 Form 144 notice Icosavax, Inc.NoticeJul 31, 2023 +28 days
Filed to sell 10,375 shares ($95k)
Holtzman Douglas, Officer
10b5-1 plan0.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2023 | Jul 31, 2023 | Icosavax, Inc. | Officer | Form 144 notice | 10,375 | $95k | Notice | SEC | |
| Jul 3, 2023 | Jul 3, 2023 | Icosavax, Inc. | Chief Scientific Officer | Form 4 sale | 16,356 | $145k | 5.3% | Routine | SEC |
| Jul 3, 2023 | Jul 3, 2023 | Icosavax, Inc. | Officer | Form 144 notice | 16,356 | $162k | Notice | SEC | |
| Apr 3, 2023 | Apr 5, 2023 | Icosavax, Inc. | Chief Scientific Officer | Form 4 sale | 20,443 | $124k | 6.6% | Routine | SEC |
| Feb 14, 2023 | Feb 15, 2023 | Icosavax, Inc. | Chief Scientific Officer | Form 4 sale | 4,871 | $50k | 1.7% | Plan not stated | SEC |
| Dec 15, 2022 | Dec 16, 2022 | Icosavax, Inc. | Chief Scientific Officer | Form 4 sale | 19,648 | $219k | 87.6% | Unusual | SEC |
| Aug 2, 2022 | Aug 2, 2022 | Icosavax, Inc. | Chief Scientific Officer | Form 4 sale | 10,375 | $69k | 3.4% | Plan not stated | SEC |